By the year 2019, “Pushchino” biopharmaceutical industrial park is scheduled to be built in the Moscow region, Russia.
This is what director general of the Development Corporation of Moscow Region JSC, Timur Andreev, said in an interview to RIAMO on Wednesday. According to him, there are 8 potential investors from Russia, Europe and Asia ready to invest 18 billion rubles in the project.
At present, the Corporation, which acts as a managing company, is engaged in leasing a plot of land for construction and ensuring financing of building infrastructure inside and outside the construction site.
Design engineering of “Pushchino” project is planned to start in the year 2017, and in 2018 the construction activities are to be launched at the site.
